These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20606123)

  • 21. Cardiac biomarkers in neonatal hypoxic ischaemia.
    Sweetman D; Armstrong K; Murphy JF; Molloy EJ
    Acta Paediatr; 2012 Apr; 101(4):338-43. PubMed ID: 22118561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers of vulnerable plaque: the missing link with ischemia.
    Muller O; Barbato E; De Bruyne B; Bartunek J
    Biomark Med; 2010 Jun; 4(3):375-83. PubMed ID: 20550471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Redefinition of myocardial infarction--relevance of biomarkers].
    Weber M; Hamm C
    Herz; 2008 Mar; 33(2):115-21. PubMed ID: 18344030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic values of various markers in evaluation of patients with chest pain.
    David DS
    Am J Cardiol; 2009 May; 103(9):1329-30. PubMed ID: 19406283
    [No Abstract]   [Full Text] [Related]  

  • 25. Activated factor XII type A and B-type natriuretic peptide are complementary and incremental predictors of mortality in patients following admission with acute coronary syndrome.
    Pönitz V; Brügger-Andersen T; Pritchard D; Grundt H; Staines H; Nilsen DW;
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):652-60. PubMed ID: 19809305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome.
    Hjortshøj S; Kristensen SR; Ravkilde J
    Am J Emerg Med; 2010 Feb; 28(2):170-6. PubMed ID: 20159386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ischemia-modified albumin in differential diagnosis of acute coronary syndrome without ST elevation and unstable angina pectoris.
    Wudkowska A; Goch J; Goch A
    Kardiol Pol; 2010 Apr; 68(4):431-7. PubMed ID: 20425705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
    Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
    J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers in clinical practice.
    Alpert JS
    Am J Med; 2011 Aug; 124(8):677-8. PubMed ID: 21683327
    [No Abstract]   [Full Text] [Related]  

  • 30. Combination of clinical risk profile, early exercise testing and circulating biomarkers for evaluation of patients with acute chest pain without ST-segment deviation or troponin elevation.
    Sanchis J; Bosch X; Bodí V; Bellera N; Núñez J; Benito B; Ordóñez J; Consuegra L; Heras M; Llècer A
    Heart; 2008 Mar; 94(3):311-5. PubMed ID: 17639094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combining natriuretic peptides and necrosis markers in the assessment of acute coronary syndromes.
    de Lemos JA; Morrow DA
    Rev Cardiovasc Med; 2003; 4 Suppl 4():S37-46. PubMed ID: 14564227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ischaemia modified albumin in the diagnosis of acute coronary syndromes.
    Pantazopoulos I; Papadimitriou L; Dontas I; Demestiha T; Iakovidou N; Xanthos T
    Resuscitation; 2009 Mar; 80(3):306-10. PubMed ID: 19111377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Markers for early detection of cardiac diseases.
    Wu AH
    Scand J Clin Lab Invest Suppl; 2005; 240():112-21. PubMed ID: 16112968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early brain natriuretic peptide increase reflects acute myocardial ischemia in patients with ongoing chest pain.
    Nikolaou NI; Kyriakides ZS; Tsaglis EP; Antonatos DG; Kartsagoulis EC; Tsigas DL
    Int J Cardiol; 2005 May; 101(2):223-9. PubMed ID: 15882668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-type natriuretic peptide-a CPK for heart-failure and beyond (ischemia)?
    Arora V; Bhandari S
    Indian Heart J; 2006; 58(2):90-2. PubMed ID: 18989049
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiac biomakers for the evaluation of acute coronary syndrome.
    Rodriguez-Ospina LF; Rosales-Alvarez CP; Lopez-Mas A
    Bol Asoc Med P R; 2009; 101(4):15-22. PubMed ID: 20853555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ischaemia modified albumin cannot be used for rapid exclusion of acute coronary syndrome.
    Lin RM; Fatovich DM; Grasko JM; Vasikaran SD
    Emerg Med J; 2010 Sep; 27(9):668-71. PubMed ID: 20466824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers in acute cardiovascular disease.
    Howie-Esquivel J; White M
    J Cardiovasc Nurs; 2008; 23(2):124-31. PubMed ID: 18382255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet glycoprotein VI (GPVI) for early identification of acute coronary syndrome in patients with chest pain.
    Bigalke B; Haap M; Stellos K; Geisler T; Seizer P; Kremmer E; Overkamp D; Gawaz M
    Thromb Res; 2010 May; 125(5):e184-9. PubMed ID: 20122713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.